Molecular diagnostics is one of the fastest growing markets in the healthcare industry, driven by the technology development (such as the third generation DNA sequencing, digital PCR and microfluidic devices), the growth of the point-of-care molecular diagnostics market, and the continued discovery of genetic biomarkers with proven clinical utility. Molecular diagnostics market is forecasted to reach $20 billion by 2030.